Paip1 Indicated Poor Prognosis in Cervical Cancer and Promoted Cervical Carcinogenesis
- Author:
Nan LI
1
;
Junjie PIAO
;
Xinyue WANG
;
Ki Yeol KIM
;
Jung Yoon BAE
;
Xiangshan REN
;
Zhenhua LIN
Author Information
- Publication Type:Original Article
- Keywords: Paip1; Uterine cervical neoplasms; Proliferation; Cell cycle; Apoptosis
- MeSH: Apoptosis; Carcinogenesis; Cell Cycle; Cell Cycle Checkpoints; Immunohistochemistry; In Vitro Techniques; Prognosis; Uterine Cervical Neoplasms
- From:Cancer Research and Treatment 2019;51(4):1653-1665
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: This study was aimed to investigate the role of poly(A)-binding protein-interacting protein 1 (Paip1) in cervical carcinogenesis. MATERIALS AND METHODS: The expression of Paip1 in normal cervical epithelial tissues and cervical cancer (CC) tissues were detected by immunohistochemistry. In vivo and in vitro assays were performed to validate effect of Paip1 on CC progression. RESULTS: Paip1 was found to be up-regulated in CC, which was linked with shorter survival. Knockdown of Paip1 inhibited cell growth, induced apoptosis and cell cycle arrest in CC cells, whereas its overexpression reversed these effects. The in vivo tumor model confirmed the pro-tumor role of Paip1 in CC growth. CONCLUSION: Altogether, the investigation demonstrated the clinical significance of Paip1 expression, which prompted that the up-regulated of Paip1 can presumably be a potential prognostic and progression marker for CC.
